Serum estrogen and tumor-positive estrogen receptor-alpha are strong prognostic classifiers of non-small-cell lung cancer survival in both men and women.

The role of tumor estrogen receptors (ERs) and serum estrogen in lung cancer is inconclusive. We investigated the hypothesis that ERs and functional single-nucleotide polymorphisms in the estrogen biosynthesis pathway are associated with poorer lung cancer survival. Lung cancer patients (n = 305) from a National Cancer Institute-Maryland (NCI-MD) case-case cohort in the Baltimore metropolitan area were used as a test cohort. To validate, 227 cases from the NCI-MD case-control cohort and 293 cases from a Norwegian lung cancer cohort were studied. Information on demographics, tobacco and reproductive histories was collected in an interviewer-administered questionnaire. Serum estrogen, progesterone, tumor messenger RNA expression of hormone receptors and germ line DNA polymorphisms were analyzed for associations with lung cancer survival. Patients in the highest tertile of serum estrogen had worse survival in all three cohorts (P combined < 0.001). Furthermore, the variant allele of estrogen receptor alpha (ER-α) polymorphism (rs2228480) was significantly associated with increased tumor ER-α levels and worse survival in all three cohorts [hazard ratio (HR) = 2.59, 95% confidence interval (CI): 1.20- 4.01; HR = 1.76, 95% CI: 1.08-2.87 and HR = 2.85, 95% CI: 1.31-4.36). Other polymorphisms associated with lower serum estrogen correlated with improved survival. Results were independent of gender and hormone replacement therapy. We report a significant association of increased serum estrogen with poorer survival among lung cancer male and female patients. Understanding the genetic control of estrogen biosynthesis and response in lung cancer could lead to improved prognosis and therapy.

[1]  J. Luketich,et al.  Human non-small cell lung tumors and cells derived from normal lung express both estrogen receptor alpha and beta and show biological responses to estrogen. , 2002, Cancer research.

[2]  G. Peters,et al.  Estrogen receptor domains E and F: role in dimerization and interaction with coactivator RIP-140. , 1999, Molecular endocrinology.

[3]  J. Gustafsson,et al.  Estrogen receptor transcription and transactivation: Basic aspects of estrogen action , 2000, Breast Cancer Research.

[4]  S. Ramalingam,et al.  Lung cancer in young patients: analysis of a Surveillance, Epidemiology, and End Results database. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  M. Fishbein,et al.  Aromatase inhibitors in human lung cancer therapy. , 2005, Cancer research.

[6]  A. Potti,et al.  Hormone replacement therapy is associated with decreased survival in women with lung cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  M. Teh,et al.  Diet, reproductive factors and lung cancer risk among Chinese women in Singapore: Evidence for a protective effect of soy in nonsmokers , 2002, International journal of cancer.

[8]  E. Wynder,et al.  Re: Endocrine factors and adenocarcinoma of the lung in women. , 1994, Journal of the National Cancer Institute.

[9]  U. G. Dailey.  Cancer,Facts and Figures about. , 2022, Journal of the National Medical Association.

[10]  S. Spivack,et al.  Gender-dependent expression of alpha and beta estrogen receptors in human nontumor and tumor lung tissue , 2002, Molecular and Cellular Endocrinology.

[11]  B. Katzenellenbogen,et al.  The carboxy-terminal F domain of the human estrogen receptor: role in the transcriptional activity of the receptor and the effectiveness of antiestrogens as estrogen antagonists. , 1995, Molecular endocrinology.

[12]  Chronic Disease Division.  Cancer facts and figures , 2010 .

[13]  M. Fishbein,et al.  Estrogen and growth factor receptor interactions in human breast and non-small cell lung cancer cells , 2005, Steroids.

[14]  R. Mentzer,et al.  Sex hormone receptors in non-small-cell lung cancer in human beings. , 1994, The Journal of thoracic and cardiovascular surgery.

[15]  Tx Station.  Stata Statistical Software: Release 7. , 2001 .

[16]  S. Olson,et al.  Variants in estrogen biosynthesis genes, sex steroid hormone levels, and endometrial cancer: a HuGE review. , 2007, American journal of epidemiology.

[17]  J. Wittliff,et al.  Steroid receptor and growth factor receptor expression in human nonsmall cell lung cancers using cells procured by laser-capture microdissection. , 2008, Advances in experimental medicine and biology.

[18]  E. Radzikowska,et al.  Estrogen and progesterone receptors in non small cell lung cancer patients. , 2002, Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia.

[19]  Y. Lee,et al.  Better prognosis of many cancers in female: A phenomenon not explained by study of steroid receptors , 1984, Journal of surgical oncology.

[20]  J. Baron.  Beneficial effects of nicotine and cigarette smoking: the real, the possible and the spurious. , 1996, British Medical Bulletin.

[21]  C. Mathers,et al.  Projections of Global Mortality and Burden of Disease from 2002 to 2030 , 2006, PLoS medicine.

[22]  H. Kawai,et al.  Estrogen receptor alpha and beta are prognostic factors in non-small cell lung cancer. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

[23]  R. Hoover,et al.  Risk of cancer in women receiving hormone replacement therapy , 1989, International journal of cancer.

[24]  A. Haugen,et al.  Expression of estrogen receptors α and β in human lung tissue and cell lines , 2002 .

[25]  A. Haugen,et al.  Expression of estrogen receptors alpha and beta in human lung tissue and cell lines. , 2002, Lung cancer.

[26]  M. Meziane,et al.  TNM staging of lung cancer: a quick reference chart. , 1999, Chest.

[27]  I. Bird,et al.  The regulation of 3β-hydroxysteroid dehydrogenase expression , 1997, Steroids.

[28]  Alan D. Lopez,et al.  Global and regional estimates of cancer mortality and incidence by site: I. Application of regional cancer survival model to estimate cancer mortality distribution by site , 2002, BMC Cancer.

[29]  C. Harris,et al.  Bleomycin-induced chromosome breaks as a risk marker for lung cancer: a case-control study with population and hospital controls. , 2003, Carcinogenesis.

[30]  Takashi Suzuki,et al.  Intracrine mechanism of estrogen synthesis in breast cancer. , 2003, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[31]  A. Schwartz,et al.  Reproductive factors, hormone use, estrogen receptor expression and risk of non small-cell lung cancer in women. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[32]  O. Lingjaerde,et al.  ESR1 gene amplification in breast cancer: a common phenomenon? , 2008, Nature Genetics.

[33]  Hideki Kawai,et al.  Estrogen Receptor α and β are Prognostic Factors in Non–Small Cell Lung Cancer , 2005, Clinical Cancer Research.

[34]  A. Miller,et al.  Reproductive and hormonal factors and risk of lung cancer in women: A prospective cohort study , 2007, International journal of cancer.

[35]  M. Fishbein,et al.  Targeting Aromatase and Estrogen Signaling in Human Non‐Small Cell Lung Cancer , 2009, Annals of the New York Academy of Sciences.

[36]  G. Sauter,et al.  Estrogen receptor alpha (ESR1) gene amplification is frequent in breast cancer , 2007, Nature Genetics.

[37]  V. Jordan,et al.  The biological role of estrogen receptors α and β in cancer , 2004 .

[38]  V. Jordan,et al.  The biological role of estrogen receptors alpha and beta in cancer. , 2004, Critical reviews in oncology/hematology.

[39]  E. White,et al.  Lung cancer and hormone replacement therapy: association in the vitamins and lifestyle study. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[40]  M. Liao,et al.  A study of the association between squamous cell carcinoma and adenocarcinoma in the lung, and history of menstruation in Shanghai women, China. , 1996, Lung cancer.

[41]  B. Ponder,et al.  Polymorphisms associated with circulating sex hormone levels in postmenopausal women. , 2005, Journal of the National Cancer Institute.

[42]  Leah E Mechanic,et al.  Polymorphisms in XPD and TP53 and mutation in human lung cancer. , 2004, Carcinogenesis.

[43]  P. Hannaford,et al.  Use of exogenous hormones by women and lung cancer: evidence from the Royal College of General Practitioners' Oral Contraception Study. , 2006, Contraception.

[44]  L. Larsson,et al.  Estrogen and progesterone receptors in non-small cell lung cancer in 248 consecutive patients who underwent surgical resection. , 2000, Archives of pathology & laboratory medicine.

[45]  J. Yager,et al.  Tissue-specific synthesis and oxidative metabolism of estrogens. , 2000, Journal of the National Cancer Institute. Monographs.

[46]  G. Alí,et al.  Different estrogen receptor beta expression in distinct histologic subtypes of lung adenocarcinoma. , 2008, Human pathology.

[47]  J. Lubin,et al.  Menstrual and Reproductive Factors and Risk of Lung Cancer among Chinese women, Eastern Gansu Province, 1994-1998 , 2007, Journal of epidemiology.

[48]  J. Manson,et al.  Oestrogen plus progestin and lung cancer in postmenopausal women (Women's Health Initiative trial): a post-hoc analysis of a randomised controlled trial , 2009, The Lancet.

[49]  I. Wistuba,et al.  Aromatase expression predicts survival in women with early-stage non small cell lung cancer. , 2007, Cancer research.

[50]  H. Pass,et al.  Nuclear Estrogen Receptor β in Lung Cancer: Expression and Survival Differences by Sex , 2005, Clinical Cancer Research.

[51]  D. Shoback,et al.  Greenspan's Basic & Clinical Endocrinology , 2007 .

[52]  J. Minna,et al.  Activity and intracellular location of estrogen receptors α and β in human bronchial epithelial cells , 2009, Molecular and Cellular Endocrinology.

[53]  J. Davie,et al.  The estrogen receptor: more than the average transcription factor. , 2002, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[54]  J. Graham,et al.  Physiological action of progesterone in target tissues. , 1997, Endocrine reviews.

[55]  Malcolm C. Pike,et al.  Personal and family history of lung disease as risk factors for adenocarcinoma of the lung. , 1988, Cancer research.

[56]  D. Sugarbaker,et al.  Menopausal effects on presentation, treatment, and survival of women with non-small cell lung cancer. , 2003, The Annals of thoracic surgery.